Currently, Breast Cancer represents nearly 30% of tumours in females and constitutes the primary cause of mortality within the female population. The detection of genetic alterations could contribute to the premature detection as well as the exhaustive aftercare of the patients in treatment.

This test, specifically the BRCA+, analyses the hereditary genes related to Breast Cancer and the genes which increase the risk of sporadic Breast Cancer.

The performance of the test is indicated in:

  • Women with medical history in direct family members.
  • Women with personal medical history.
  • Patients who wish to carry out studies regarding their personal risks or susceptibility to develop them.

With the help of the results, the following medical treatment is adjusted in a totally personalised way.